18F-FES
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for 18F-FES, covering 2024-04-29 to 2025-11-24. Get the full timeline:
Most recent: Clinical Trial Update: Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer [Phase 4]